Does folic acid supplementation rescue defects in ECE-1-deficient mouse embryos?

Area of Science:

• Developmental Biology
• Genetics
• Pharmacology

Background:

• Endothelin (ET) signaling is crucial for embryonic development, with disruptions causing neural crest derivative defects.
• Endothelin-converting enzyme 1 (ECE-1) regulates ET-1 biosynthesis, a key component of this pathway.
• Folic acid (FA) is investigated for its potential role in preventing congenital anomalies by influencing ET-1 expression.

Purpose of the Study:

• To determine if folic acid (FA) supplementation can rescue craniofacial and cardiac defects in ECE-1 deficient (ECE1-/-) mouse embryos.
• To investigate the impact of FA on embryonic development and gene expression in the context of ECE-1 deficiency.

Main Methods:

• ECE1+/- mice were used to generate litters with various genotypes.
• A subset of pregnant mice received a diet supplemented with 20 mg/kg FA from vaginal plug discovery.
• Craniofacial and cardiac morphology, embryonic viability, litter size, and ET receptor A expression were assessed.

Main Results:

• FA supplementation did not alter genotype proportions or rescue embryonic lethality in ECE1-/- embryos.
• Craniofacial and cardiac defects were present in ECE1-/- embryos regardless of FA treatment.
• Mildly reduced embryo size and hemorrhages were observed in FA-supplemented wild-type and heterozygous embryos; ET receptor A expression was upregulated in ECE1-/- embryos without response to FA.

Conclusions:

• Folic acid (FA) supplementation is ineffective in rescuing developmental defects associated with ECE-1 deficiency in this mouse model.
• The protective mechanisms of FA against congenital anomalies may involve pathways independent of ET-1 signaling regulated by ECE-1.
• Results caution against the uncritical use of dietary supplements for preventing congenital anomalies, highlighting the need for targeted approaches.